Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
14000,,,5222410,[],CHEMBL1674339,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332010,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.125
14001,,,5222411,[],CHEMBL1674338,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332010,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.125
14002,,Not Determined,5222412,[],CHEMBL1674337,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332010,,1,0,,,MIC,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,,,,
14003,,Not Determined,5222413,[],CHEMBL1674336,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332010,,1,0,,,MIC,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,,,,
14004,,Not Determined,5222414,[],CHEMBL1674335,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332010,,1,0,,,MIC,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,,,,
14005,,Not Determined,5225757,[],CHEMBL1677380,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay,B,,,BAO_0002114,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332425,,1,0,,,Time,,,,CHEMBL612545,,Unchecked,,,,Time,,,,
14006,,,5225784,[],CHEMBL1677379,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay,B,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1332425,=,1,1,=,,TIME,hr,,0.005556,CHEMBL612545,,Unchecked,,,,Time,s,UO_0000032,,20.0
14007,,,5226251,[],CHEMBL1674838,Antimicrobial activity against Escherichia coli isolate GZ3 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14008,,,5226252,[],CHEMBL1674839,Antimicrobial activity against Escherichia coli isolate GZ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14009,,,5226253,[],CHEMBL1674840,Antimicrobial activity against Escherichia coli isolate GZ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14010,,,5226254,[],CHEMBL1674841,Antimicrobial activity against Escherichia coli isolate GZ6 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14011,,,5226255,[],CHEMBL1674842,Antimicrobial activity against Escherichia coli isolate GZ8 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14012,,,5226256,[],CHEMBL1674843,Antimicrobial activity against Escherichia coli isolate GZ9 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14013,,,5226257,[],CHEMBL1674844,Antimicrobial activity against Escherichia coli isolate GZ11 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14014,,,5226258,[],CHEMBL1674845,Antimicrobial activity against Escherichia coli isolate GZ12 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14015,,,5226259,[],CHEMBL1674846,Antimicrobial activity against Escherichia coli isolate GZ13 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14016,,,5226260,[],CHEMBL1674847,Antimicrobial activity against Escherichia coli isolate GZ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14017,,,5226261,[],CHEMBL1674848,Antimicrobial activity against Escherichia coli isolate GZ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14018,,,5226262,[],CHEMBL1674849,Antimicrobial activity against Escherichia coli isolate GZ16 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14019,,,5226263,[],CHEMBL1674850,Antimicrobial activity against Escherichia coli isolate CQ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14020,,,5226264,[],CHEMBL1674851,Antimicrobial activity against Escherichia coli isolate CQ18 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
14021,,,5226265,[],CHEMBL1674852,Antimicrobial activity against Escherichia coli isolate CQ2 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14022,,,5226266,[],CHEMBL1674853,Antimicrobial activity against Escherichia coli isolate CQ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14023,,,5226267,[],CHEMBL1674854,Antimicrobial activity against Escherichia coli isolate CQ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
14024,,,5226268,[],CHEMBL1674855,Antimicrobial activity against Escherichia coli isolate CQ20 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14025,,,5226269,[],CHEMBL1674856,Antimicrobial activity against Escherichia coli isolate CQ26 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14026,,,5226270,[],CHEMBL1674857,Antimicrobial activity against Escherichia coli isolate CQ10 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,32.0
14027,,,5226271,[],CHEMBL1674972,Antimicrobial activity against Escherichia coli isolate CQ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,32.0
14028,,,5226272,[],CHEMBL1674973,Antimicrobial activity against Escherichia coli isolate GZ7 transconjugant harboring 16S rRNA methylase RmtB and qepA and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14029,,,5226273,[],CHEMBL1674974,Antimicrobial activity against Escherichia coli isolate GZ1 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14030,,,5226274,[],CHEMBL1674975,Antimicrobial activity against Escherichia coli isolate GZ2 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
14031,,,5226275,[],CHEMBL1674976,Antimicrobial activity against Escherichia coli isolate CQ22 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
14032,,,5226276,[],CHEMBL1674977,Antimicrobial activity against Escherichia coli isolate CQ13 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,4.0
14033,,,5226277,[],CHEMBL1674978,"Antimicrobial activity against Escherichia coli isolate CQ6 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14034,,,5226278,[],CHEMBL1674979,"Antimicrobial activity against Escherichia coli isolate CQ7 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14035,,,5226279,[],CHEMBL1674980,"Antimicrobial activity against Escherichia coli isolate CQ12 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14036,,,5226280,[],CHEMBL1674981,"Antimicrobial activity against Escherichia coli isolate CQ16 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14037,,,5226281,[],CHEMBL1674982,"Antimicrobial activity against Escherichia coli isolate GZ10 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14038,,,5226282,[],CHEMBL1674983,"Antimicrobial activity against Escherichia coli isolate CQ19 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,16.0
14039,,,5226283,[],CHEMBL1674984,Antimicrobial activity against Escherichia coli isolate CQ1 transconjugant harboring 16S rRNA methylase RmtB and qnrB6 by agar dilution method relative to recipient strain,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671858,Antimicrob Agents Chemother,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1331640,=,1,0,=,,FC,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,2.0
14040,,,5228095,[],CHEMBL1679709,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
14041,,,5228096,[],CHEMBL1679710,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.001
14042,,,5228097,[],CHEMBL1679711,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
14043,,,5228098,[],CHEMBL1679712,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.001
14044,,,5228099,[],CHEMBL1680414,Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332076,=,1,0,=,,Ratio,,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,2.0
14045,,,5228100,[],CHEMBL1680415,Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
14046,,,5228101,[],CHEMBL1680416,Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,256.0
14047,,,5228102,[],CHEMBL1680417,Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC0037,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332076,=,1,0,=,,Ratio,,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Ratio,,,,2.0
14048,,,5228103,[],CHEMBL1680418,Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671677,Antimicrob Agents Chemother,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332076,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
14049,,,5230094,[],CHEMBL1676244,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZN10 containing cat and bla genes by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
14050,,,5230095,[],CHEMBL1676245,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2396-encoded QacA gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
14051,,,5230096,[],CHEMBL1676246,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2182-encoded QacBII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
14052,,,5230097,[],CHEMBL1676247,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14053,,,5230098,[],CHEMBL1676248,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2162-encoded QacBIII E320A mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
14054,,,5230099,[],CHEMBL1676249,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332569,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.13
14055,,Not Determined,5230100,[],CHEMBL1676250,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A19T mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
14056,,Not Determined,5230101,[],CHEMBL1676251,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV S151I mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
14057,,Not Determined,5230102,[],CHEMBL1676252,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV A184V mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
14058,,Not Determined,5230103,[],CHEMBL1676253,Antimicrobial activity against Staphylococcus aureus RDN1 harboring cloned pTZ2238-encoded QacBIV E377G mutant gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
14059,,Active,5230104,[],CHEMBL1676254,Activity of antiseptic efflux protein QacBIII expressed in Staphylococcus aureus RDN1 assessed as decrease in compound accumulation,B,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
14060,,Not Active,5230105,[],CHEMBL1676255,Activity of antiseptic efflux protein QacBIII expressed in Staphylococcus aureus RDN1 assessed as decrease in compound accumulation in presence of CCCP,B,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1671731,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1332569,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
14061,,,5296523,[],CHEMBL1692065,Antibacterial activity against wild type Escherichia coli BW25113,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
14062,,,5296524,[],CHEMBL1692066,Antibacterial activity against tolC deficient Escherichia coli GD100,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
14063,,,5296525,[],CHEMBL1692067,Antibacterial activity against speE deficient Escherichia coli JW0117-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
14064,,,5296526,[],CHEMBL1692068,Antibacterial activity against gshB deficient Escherichia coli JW2914-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
14065,,,5296527,[],CHEMBL1692069,Antibacterial activity against gspS deficient Escherichia coli JW2956-1,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
14066,,,5296528,[],CHEMBL1692070,"Antibacterial activity against ygiBC, yjfMC, gspS deficient Escherichia coli GD108",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
14067,,,5296529,[],CHEMBL1692071,"Antibacterial activity against tolC, speE deficient Escherichia coli GD106",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.005
14068,,,5296530,[],CHEMBL1692072,"Antibacterial activity against tolC, gshB deficient Escherichia coli GD107",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.0025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0025
14069,,,5296531,[],CHEMBL1692073,Antibacterial activity against wild type Escherichia coli BW25113 absence of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.04
14070,,,5296532,[],CHEMBL1692074,Antibacterial activity against wild type Escherichia coli BW25113 presence of 5 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.16
14071,,,5296533,[],CHEMBL1692075,Antibacterial activity against wild type Escherichia coli BW25113 presence of 10 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.64,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.64
14072,,,5296534,[],CHEMBL1692076,Antibacterial activity against wild type Escherichia coli BW25113 presence of 15 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,1.28,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.28
14073,,,5296535,[],CHEMBL1692077,Antibacterial activity against tolC deficient Escherichia coli GD100 absence of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
14074,,,5296536,[],CHEMBL1692078,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 5 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
14075,,,5296537,[],CHEMBL1692079,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 10 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.08,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.08
14076,,Active,5296538,[],CHEMBL1692080,Antibacterial activity against tolC deficient Escherichia coli GD100 presence of 15 mM of glutathione,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338241,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
14077,,,5296539,[],CHEMBL1692081,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE absence of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.005,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.005
14078,,,5296540,[],CHEMBL1692082,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 5 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
14079,,,5296541,[],CHEMBL1692083,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 10 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.02
14080,,,5296542,[],CHEMBL1692084,"Antibacterial activity against kanamycin-resistant acrAB, acrEF deficient Escherichia coli W4680AE presence of 15 mM of glutathione",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687812,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338241,=,1,1,=,,MIC,ug.mL-1,,0.16,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.16
14081,,,5297366,[],CHEMBL1692132,Ratio of MIC for marA-overproducing Escherichia coli CR1000 to MIC for MarA-deficient Escherichia coli CR2000,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1337772,=,1,0,=,,Ratio,,,3.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,3.1
14082,,,5297395,[],CHEMBL1692129,Antibacterial activity against wild-type Escherichia coli BW25113 after 20 hrs by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337772,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.09
14083,,,5297396,[],CHEMBL1692130,Antibacterial activity against MarA-deficient Escherichia coli CR2000 after 20 hrs by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337772,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.07
14084,,,5297397,[],CHEMBL1692131,Antibacterial activity against MarA-overexpressing Escherichia coli CR1000 after 20 hrs by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337772,=,1,1,=,,MIC,ug.mL-1,,0.21,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.21
14085,,,5297398,[],CHEMBL1692133,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated cspGp gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14086,,,5297399,[],CHEMBL1692134,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated ompR gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,77.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,77.0
14087,,,5297400,[],CHEMBL1692135,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated appA gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,84.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,84.0
14088,,,5297401,[],CHEMBL1692136,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated degP gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14089,,,5297402,[],CHEMBL1692137,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated maoC gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,61.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,61.0
14090,,,5297403,[],CHEMBL1692800,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated metL gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14091,,,5297404,[],CHEMBL1692801,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated recD gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,77.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,77.0
14092,,,5297405,[],CHEMBL1692802,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated treC gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,46.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,46.0
14093,,,5297406,[],CHEMBL1692803,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated ynfE gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,68.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,68.0
14094,,,5297407,[],CHEMBL1692804,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated mhpT gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14095,,,5297408,[],CHEMBL1692934,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated nikD gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,68.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,68.0
14096,,,5297409,[],CHEMBL1692935,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated alx gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,68.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,68.0
14097,,,5297410,[],CHEMBL1692936,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated metV gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14098,,,5297411,[],CHEMBL1692937,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated yfdG gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,91.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,91.0
14099,,,5297412,[],CHEMBL1692938,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated yibLp gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,68.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,68.0
14100,,,5297413,[],CHEMBL1692939,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated yniDp gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,77.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,77.0
14101,,,5297414,[],CHEMBL1692940,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated hns gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,23.0
14102,,,5297415,[],CHEMBL1692941,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated cyaA gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,41.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,41.0
14103,,,5297416,[],CHEMBL1692942,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated pcnB gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,23.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,23.0
14104,,,5297417,[],CHEMBL1692943,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated acrA gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
14105,,,5297418,[],CHEMBL1692944,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated acrB gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,9.0
14106,,,5297419,[],CHEMBL1692945,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated tolC gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,0.0
14107,,,5297420,[],CHEMBL1692946,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated damX gene assessed as MarA-mediated multidrug resistance level by measuring fold decrease in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,46.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,46.0
14108,,,5297474,[],CHEMBL1692947,Antibacterial activity against marA-overproducing Escherichia coli CR1000 harboring inactivated crp gene assessed as MarA-mediated multidrug resistance level by measuring fold change in MIC relative to MarA-deficient Escherichia coli CR2000,F,,,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687757,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,1337772,=,1,0,=,,Activity,%,,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,33.0
14109,,,5299681,[],CHEMBL1691813,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
14110,,,5299682,[],CHEMBL1691809,Antibacterial activity against wild type Streptococcus pneumoniae M3 NCTC 7466 type 2 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
14111,,,5299689,[],CHEMBL1691812,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
14112,,,5299690,[],CHEMBL1691810,Antibacterial activity against wild type Streptococcus pneumoniae M4 NCTC 7465 type 1 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
14113,,,5299697,[],CHEMBL1691811,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
14114,,,5299698,[],CHEMBL1691808,Antibacterial activity against wild type Streptococcus pneumoniae R6 by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
14115,,,5299705,[],CHEMBL1691804,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
14116,,,5299706,[],CHEMBL1691803,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
14117,,,5299713,[],CHEMBL1691804,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,32.0
14118,,,5299714,[],CHEMBL1691803,"Antibacterial activity against fluoroquinolone, dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
14119,,,5299721,[],CHEMBL1691815,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
14120,,,5299722,[],CHEMBL1691816,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
14121,,,5299729,[],CHEMBL1691815,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,32.0
14122,,,5299730,[],CHEMBL1691816,Antibacterial activity against fluoroquinolone-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,8.0
14123,,,5299737,[],CHEMBL1691818,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
14124,,,5299738,[],CHEMBL1692614,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
14125,,,5299745,[],CHEMBL1691818,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
14126,,,5299746,[],CHEMBL1692614,Antibacterial activity against dye-resistant Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
14127,,,5299753,[],CHEMBL1692616,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
14128,,,5299754,[],CHEMBL1692617,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
14129,,,5299761,[],CHEMBL1692616,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
14130,,,5299762,[],CHEMBL1692617,"Antibacterial activity against fluoroquinolone, dye-susceptible Streptococcus pneumoniae by standardized agar doubling dilution method in presence of 20 ug/ml reserpine efflux pump inhibitor",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687824,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338448,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
14131,,,5307519,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
14132,,,5307520,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14133,,,5307521,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14134,,,5307522,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14135,,,5307523,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14136,,,5307524,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14137,,,5307525,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14138,,,5307526,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14139,,,5307527,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
14140,,,5307528,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14141,,,5307529,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14142,,,5307530,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14143,,,5307531,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14144,,,5307532,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
14145,,,5307533,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
14146,,,5307534,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
14147,,,5307535,[],CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,4.0
14148,,,5307536,[],CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
14149,,,5307537,[],CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
14150,,,5307538,[],CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
14151,,,5307539,[],CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,8.0
14152,,,5307540,[],CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
14153,,,5307541,[],CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,16.0
14154,,,5307542,[],CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,ug ml-1,UO_0000274,,32.0
14155,,,5307543,[],CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,266.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,266.7
14156,,,5307544,[],CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
14157,,,5307545,[],CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
14158,,,5307546,[],CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
14159,,,5307547,[],CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,32.0
14160,,,5307548,[],CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
14161,,,5307549,[],CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
14162,,,5307550,[],CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1338563,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
14163,,,5307551,[],CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
14164,,,5307552,[],CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14165,,,5307553,[],CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
14166,,,5307554,[],CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14167,,,5307555,[],CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14168,,,5307556,[],CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14169,,,5307557,[],CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14170,,,5307558,[],CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,1338563,=,1,1,=,,TIME,hr,,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,24.0
14171,,,5307559,[],CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14172,,,5308593,[],CHEMBL1691501,Antimicrobial activity against Escherichia coli C600 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
14173,,,5308594,[],CHEMBL1691502,Antimicrobial activity against oqxAB positive Escherichia coli C600 W281-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14174,,,5308595,[],CHEMBL1691503,Antimicrobial activity against oqxAB positive Escherichia coli C600 W191-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14175,,,5308596,[],CHEMBL1691504,Antimicrobial activity against oqxAB positive Escherichia coli C600 W322-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14176,,,5308597,[],CHEMBL1691505,Antimicrobial activity against oqxAB positive Escherichia coli C600 W245-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14177,,,5308598,[],CHEMBL1691506,Antimicrobial activity against oqxAB positive Escherichia coli C600 G262-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14178,,,5308599,[],CHEMBL1691507,Antimicrobial activity against oqxAB positive Escherichia coli C600 G062-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14179,,,5308600,[],CHEMBL1691508,Antimicrobial activity against oqxAB positive Escherichia coli C600 G375-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14180,,,5308601,[],CHEMBL1691509,Antimicrobial activity against oqxAB positive Escherichia coli C600 X1B1-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14181,,,5308602,[],CHEMBL1691510,Antimicrobial activity against oqxAB positive Escherichia coli C600 XT11-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14182,,,5308603,[],CHEMBL1691511,Antimicrobial activity against oqxAB positive Escherichia coli C600 SW8-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14183,,,5308604,[],CHEMBL1691512,"Antimicrobial activity against Escherichia coli C600 ST2-T transconjugant harboring oqxAB, qnrB6 and aac(6')-Ib-cr genes by CLSI agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
14184,,,5308605,[],CHEMBL1691513,Antimicrobial activity against oqxAB positive Escherichia coli C600 SP8-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14185,,,5308606,[],CHEMBL1691514,Antimicrobial activity against oqxAB positive Escherichia coli C600 D83-T transconjugant by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
14186,,,5308607,[],CHEMBL1691515,Antimicrobial activity against oqxAB positive Escherichia coli DH5[alpha] harboring pMD18-T::oqxAB by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14187,,,5308608,[],CHEMBL1691516,Antimicrobial activity against Escherichia coli DH5[alpha] by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687783,Antimicrob Agents Chemother,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337903,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
14188,,,5308640,[],CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14189,,,5308641,[],CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14190,,,5308642,[],CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14191,,,5308643,[],CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14192,,,5308644,[],CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
14193,,,5308645,[],CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14194,,,5308646,[],CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14195,,,5308647,[],CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.03
14196,,,5308648,[],CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
14197,,,5308649,[],CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
14198,,,5308650,[],CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
14199,,,5308651,[],CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
14200,,,5308652,[],CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
14201,,,5308653,[],CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,1.0
14202,,,5308654,[],CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
14203,,,5308655,[],CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.03
14204,,,5308656,[],CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
14205,,,5308657,[],CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
14206,,,5308658,[],CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.5
14207,,,5308659,[],CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,2.0
14208,,,5308660,[],CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,64.0
14209,,,5308661,[],CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,4.0
14210,,,5308662,[],CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338563,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,16.0
14211,,,5308888,[],CHEMBL1692836,Antibacterial activity against 5 x 10'5 CFU/ml Staphylococcus aureus ATCC 25923 expressing TetK tetracycline efflux protein after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14212,,,5308889,[],CHEMBL1692837,Antibacterial activity against 5 x 10'5 CFU/ml epidemic methicillin-resistant Staphylococcus aureus EMRSA-15 after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14213,,,5308890,[],CHEMBL1692838,Antibacterial activity against 5 x 10'5 CFU/ml epidemic methicillin-resistant Staphylococcus aureus EMRSA-16 after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
14214,,,5308891,[],CHEMBL1692839,Antibacterial activity against 5 x 10'5 CFU/ml macrolide-resistant Staphylococcus aureus RN4220 expressing MsrA macrolide efflux protein after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14215,,,5308892,[],CHEMBL1692840,Antibacterial activity against 5 x 10'5 CFU/ml multi-drug-resistant Staphylococcus aureus SA1199B expressing NorA quinolone efflux protein after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
14216,,,5308893,[],CHEMBL1692841,Antibacterial activity against 5 x 10'5 CFU/ml multi-drug-resistant Staphylococcus aureus XU212 expressing TetK tetracycline efflux protein after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1687851,J Nat Prod,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338588,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14217,,drug-induced liver injury reported,5317664,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341450,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
14218,,drug-induced liver injury reported,5318615,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341450,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
14219,,no drug-induced liver injury reported,5319566,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341450,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
14220,,Active,5320275,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
14221,,,5320276,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,Composite Activity - Active,,,2.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,2.0
14222,,,5320277,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,Composite Activity - Marginal,,,2.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,2.0
14223,,Active,5320278,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
14224,,,5320279,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,>=,1,0,>=,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
14225,,,5320280,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,6.3,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,6.3
14226,,Active,5320281,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
14227,,,5320282,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,>=,1,0,>=,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
14228,,,5320283,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,SGOT Increase - Index Value,,,5.6,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,5.6
14229,,Marginally Active,5320284,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
14230,,,5320285,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,SGPT Increase - Index Value,,,3.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,3.0
14231,,,5320286,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,>=,1,0,>=,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
14232,,Marginally Active,5320287,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
14233,,,5320288,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,LDH Increase - Index Value,,,3.7,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,3.7
14234,,,5320289,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,>=,1,0,>=,,LDH Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,4.0
14235,,Inactive,5320290,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
14236,,,5320291,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,=,1,0,=,,GGT Increase - Index Value,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,0.0
14237,,,5320292,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1341980,<,1,0,<,,GGT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,4.0
14238,,inconclusive,5526983,[],CHEMBL1738606,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,978440,,7,1,,,Potency,nM,,15848.9,CHEMBL5501,Homo sapiens,Histone acetyltransferase GCN5,9606.0,,,Potency,uM,UO_0000065,,15.8489
14239,,Active,5780406,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1297959,,7,1,,,Potency,nM,,8912.5,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,8.9125
14240,,,5986583,[],CHEMBL1112930,Absolute bioavailability in human,A,,,BAO_0003042,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1158536,J Med Chem,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,910322,=,1,1,=,,F,%,,35.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,F,%,UO_0000187,,35.0
14241,,inactive,5993135,[],CHEMBL1741325,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,978440,,7,0,,,AC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,AC50,,,,
14242,,inactive,6024630,[],CHEMBL1741321,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,978440,,7,0,,,AC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,AC50,,,,
14243,,inactive,6028056,[],CHEMBL1741324,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,978440,,7,0,,,AC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,AC50,,,,
14244,,inactive,6030425,[],CHEMBL1741322,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,978440,,7,0,,,AC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,AC50,,,,
14245,,inactive,6031329,[],CHEMBL1741323,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,978440,,7,0,,,AC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,AC50,,,,
14246,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Inhibitor,6074578,[],CHEMBL1743274,"Clinically relevant inhibitors of human liver microsomal P450 enzymes, isoform CYP1A2",A,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1743201,,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1394254,,1,0,,,Activity,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Activity,,,,
14247,,,6151956,[],CHEMBL1763336,Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413650,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.39
14248,,,6151980,[],CHEMBL1763337,Antibacterial activity against methicillin- resistant Staphylococcus aureus ATCC 25923 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413650,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
14249,,,6152004,[],CHEMBL1763338,Antibacterial activity against methicillin- resistant and vancomycin resistant Staphylococcus aureus ATCC 29213 after 24 hrs by spectrophotometry,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1759957,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1413650,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
14250,,,6256331,[],CHEMBL1799707,Antibacterial activity against vancomycin resistant Enterococcus FN-1 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,128.0
14251,,,6256349,[],CHEMBL1799708,Antibacterial activity against vancomycin resistant Enterococcus NCTC 12201 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,4.0
14252,,,6256395,[],CHEMBL1799709,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
14253,,,6256424,[],CHEMBL1799710,Antibacterial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14254,,,6256460,[],CHEMBL1799711,Antibacterial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
14255,,,6256479,[],CHEMBL1799712,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14256,,,6257126,[],CHEMBL1799713,Antibacterial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
14257,,,6257158,[],CHEMBL1798193,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 209P after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14258,,,6257188,[],CHEMBL1799897,Antibacterial activity against Streptococcus pneumoniae R6 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
14259,,,6257217,[],CHEMBL1799898,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
14260,,,6257240,[],CHEMBL1799899,Antibacterial activity against Escherichia coli K-12 after 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437272,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
14261,,,6257281,[],CHEMBL1799901,Inhibition of Escherichia coli DNA gyrase assessed as inhibition of pBR322 supercoiling by densitometry,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,7.05,0,http://www.openphacts.org/units/Nanomolar,1437272,=,1,1,=,,IC50,nM,,90.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.09
14262,,,6257328,[],CHEMBL1799902,Inhibition of Staphylococcus aureus DNA Topoisomerase 4-mediated decatenation of kDNA after 30 mins by densitometry,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,5.46,0,http://www.openphacts.org/units/Nanomolar,1437272,=,1,1,=,,IC50,nM,,3500.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,3.5
14263,,Not Determined,6257361,[],CHEMBL1799903,Inhibition of Escherichia coli DNA topoisomerase 4 subunit ParC/DNA topoisomerase 4 subunit ParE-mediated decatenation of kDNA by densitometry,B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795235,J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1437272,,1,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14264,,,6262191,[],CHEMBL1798462,Unbound drug concentration in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,1438398,=,1,0,=,,Cp(f),uM,,0.7,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Cp(f),uM,UO_0000064,,0.7
14265,,,6262234,[],CHEMBL1798463,Unbound volume of distribution in Sprague-Dawley rat brain measured per gram of brain tissue administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,0,=,,Vdu,ml,,2.9,CHEMBL613617,Rattus norvegicus,Brain,10116.0,,,Vdu,ml,UO_0000098,,2.9
14266,,,6262277,[],CHEMBL1798464,Fraction unbound in Sprague-Dawley rat plasma administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,1,=,,Fu,,,0.87,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,Fu,,,,0.87
14267,,,6262320,[],CHEMBL1798465,Ratio of total drug level in brain to plasma in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,0,=,,BPR,,,0.07,CHEMBL612558,,ADMET,,,,BPR,,,,0.07
14268,,,6262363,[],CHEMBL1798466,Unbound brain to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,0,=,,"K(p,uu,brain)",,,0.028,CHEMBL612558,,ADMET,,,,"K(p,uu,brain)",,,,0.028
14269,,,6262405,[],CHEMBL1798467,Unbound CSF to plasma concentration ratio in Sprague-Dawley rat administered in casettes of 2/3 drugs at 4 hr constant rate intravenous infusions using flow rate of 1 (ml/kg)/hr corresponding to dosage rate of 2 (umol/kg)/hr by LC-MS/MS method,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,0,=,,"K(p,uu,CSF)",,,0.018,CHEMBL613652,Rattus norvegicus,Plasma,10116.0,,,"K(p,uu,CSF)",,,,0.018
14270,,,6263045,[],CHEMBL1798468,Unbound CSF to plasma concentration ratio in human,A,,,BAO_0000179,BAO_0000366,cell-free format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1795238,J Med Chem,2009.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1438398,=,1,0,=,,"K(p,uu,CSF)",,,0.11,CHEMBL613424,Homo sapiens,Plasma,9606.0,,,"K(p,uu,CSF)",,,,0.11
14271,,,6293563,[],CHEMBL1811467,Antibacterial activity against 10'5 CFU/mL Staphylococcus aureus RN4220 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14272,,,6293603,[],CHEMBL1811468,Antibacterial activity against 10'5 CFU/mL Staphylococcus aureus KCTC 503 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14273,,,6293643,[],CHEMBL1811469,Antibacterial activity against 10'5 CFU/mL Escherichia coli 1356 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14274,,,6293683,[],CHEMBL1811470,Antibacterial activity against 10'5 CFU/mL Escherichia coli 1682 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14275,,,6293690,[],CHEMBL1811471,Antibacterial activity against 10'5 CFU/mL methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14276,,,6293697,[],CHEMBL1811472,Antibacterial activity against 10'5 CFU/mL methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14277,,,6293704,[],CHEMBL1811473,Antibacterial activity against 10'5 CFU/mL quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14278,,,6293711,[],CHEMBL1811474,Antibacterial activity against 10'5 CFU/mL quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as inhibition of bacterial growth after 24 hrs by microtiter enzyme-linked immunosorbent assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1806444,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1444435,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14279,,,6334983,[],CHEMBL1820022,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14280,,,6335012,[],CHEMBL1820054,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
14281,,,6335041,[],CHEMBL1820021,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14282,,,6335070,[],CHEMBL1820024,Antibacterial activity against Escherichia coli ATCC 8099 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
14283,,,6335099,[],CHEMBL1820020,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
14284,,,6335128,[],CHEMBL1820019,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1817584,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1451554,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,1.0
14285,,,6366575,[],CHEMBL1833489,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by colony forming unit determination,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457382,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,5.0
14286,,,6366593,[],CHEMBL1833490,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis A8 241 after 28 days by colony forming unit determination,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1457382,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,10.0
14287,,,6366611,[],CHEMBL1833491,"Selectivity index, ratio of IC50 for human HepG2 cells to MIC for Mycobacterium tuberculosis H37Rv ATCC 27294",F,,,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1457382,=,1,0,=,,Selectivity Index,,,31.85,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,31.85
14288,,,6366629,[],CHEMBL1833492,"Selectivity index, ratio of IC50 for human HepG2 cells to MIC for multidrug-resistant Mycobacterium tuberculosis A8 241",F,,,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1457382,=,1,0,=,,Selectivity Index,,,15.87,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,15.87
14289,,,6366647,[],CHEMBL1833493,Antimycobacterial activity against Mycobacterium avium CNTC 330/88 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,125000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,125.0
14290,,,6366666,[],CHEMBL1833494,Antimycobacterial activity against Mycobacterium avium CNTC 330/88 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,250000.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC,umol/L,UO_0000065,,250.0
14291,,,6367359,[],CHEMBL1833495,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,8000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,8.0
14292,,,6367378,[],CHEMBL1833496,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,16000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,16.0
14293,,,6367397,[],CHEMBL1833497,Antimycobacterial activity against Mycobacterium kansasii CNTC My 235/80 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,16000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,16.0
14294,,,6367416,[],CHEMBL1833498,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,2000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,2.0
14295,,,6367435,[],CHEMBL1833499,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 14 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,8000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,8.0
14296,,,6367454,[],CHEMBL1833500,Antimycobacterial activity against Mycobacterium kansasii CNTC 6509/96 after 21 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,=,1,1,=,,MIC,nM,,8000.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,,MIC,umol/L,UO_0000065,,8.0
14297,,,6367472,[],CHEMBL1833501,Cytotoxicity against human HepG2 cells measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,>,1,1,>,,IC50,nM,,500000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
14298,,,6367489,[],CHEMBL1833502,Cytotoxicity against human PBMC measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,>,1,1,>,,IC50,nM,,500000.0,CHEMBL613107,Homo sapiens,PBMC,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
14299,,,6367506,[],CHEMBL1833503,Cytotoxicity against human SH-SY5Y cells measured after overnight incubation by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1828506,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1457382,>,1,1,>,,IC50,nM,,500000.0,CHEMBL614910,Homo sapiens,SH-SY5Y,9606.0,,,IC50,mmol/L,UO_0000065,,0.5
14300,,,6375856,[],CHEMBL1839988,Antibacterial activity against 10'8 CFU/mL Bacillus subtilis MTCC 441 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14301,,,6375873,[],CHEMBL1839989,Antibacterial activity against 10'8 CFU/mL Streptococcus pyogenes MTCC 442 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14302,,,6375890,[],CHEMBL1839990,Antibacterial activity against 10'8 CFU/mL Staphylococcus aureus MTCC 96 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14303,,,6375907,[],CHEMBL1839991,Antibacterial activity against 10'8 CFU/mL Salmonella typhi MTCC 98 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14304,,,6375924,[],CHEMBL1839992,Antibacterial activity against 10'8 CFU/mL Klebsiella pneumoniae MTCC 109 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14305,,,6375941,[],CHEMBL1839994,Antibacterial activity against 10'8 CFU/mL Pseudomonas aeruginosa MTCC 1688 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14306,,,6375958,[],CHEMBL1839993,Antibacterial activity against 10'8 CFU/mL Escherichia coli MTCC 443 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833842,Eur J Med Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460743,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14307,,,6377133,[],CHEMBL1838715,Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,10.0
14308,,,6377144,[],CHEMBL1838890,Antibacterial activity against Escherichia coli 700 expressing TolC after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.059,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.059
14309,,,6377155,[],CHEMBL1838891,Antibacterial activity against TolC deficient Escherichia coli 701 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.039,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.039
14310,,,6377166,[],CHEMBL1838892,Antibacterial activity against Pseudomonas aeruginosa PAO1 ATCC BAA-47 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.25
14311,,,6377177,[],CHEMBL1838893,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring oprM deltamexAB after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.039,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.039
14312,,,6377188,[],CHEMBL1838894,Antibacterial activity against Stenotrophomonas maltophilia ATCC 13637 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,1.25
14313,,,6377199,[],CHEMBL1838895,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.938,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.938
14314,,,6377210,[],CHEMBL1838896,Antibacterial activity against Bacillus subtilis BD54 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.625,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.625
14315,,,6377221,[],CHEMBL1838897,Antibacterial activity against Bacillus anthracis Sterne after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.313,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,,0.313
14316,,,6377232,[],CHEMBL1838898,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
14317,,,6377243,[],CHEMBL1838899,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1094 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
14318,,,6377254,[],CHEMBL1838900,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.5
14319,,,6377265,[],CHEMBL1838901,Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.5
14320,,,6377276,[],CHEMBL1838902,Antibacterial activity against Burkholderia cepacia ATCC 39277 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,1.25
14321,,,6377287,[],CHEMBL1838903,Antibacterial activity against Burkholderia cepacia ATCC 55792 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,ug ml-1,UO_0000274,,2.5
14322,,,6377298,[],CHEMBL1838904,Antibacterial activity against Escherichia coli ATCC 29425 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
14323,,,6377308,[],CHEMBL1838905,Antibacterial activity against Escherichia coli ATCC 29425 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.01,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.01
14324,,,6377318,[],CHEMBL1838906,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14325,,,6377328,[],CHEMBL1838907,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16 to 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
14326,,,6377338,[],CHEMBL1838908,Antibacterial activity against Klebsiella pneumoniae ATCC 13882 after 18 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833882,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1460425,=,1,1,=,,MIC,ug.mL-1,,0.117,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.117
14327,,,6379943,[],CHEMBL1839543,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14328,,,6379971,[],CHEMBL1839544,Antimicrobial activity against Clostridium tetani MTCC 449 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14329,,,6379999,[],CHEMBL1839545,Antimicrobial activity against Bacillus subtilis MTCC 441 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14330,,,6380027,[],CHEMBL1839546,Antimicrobial activity against Salmonella typhi MTCC 98 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14331,,,6380055,[],CHEMBL1839547,Antimicrobial activity against Vibrio cholerae MTCC 3906 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14332,,,6380982,[],CHEMBL1839548,Antimicrobial activity against Escherichia coli MTCC 443 for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1833797,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1461371,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14333,,inconclusive,6667578,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1297959,,7,1,,,Potency,nM,,1651.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,1.6511
14334,,active,6672324,[],CHEMBL1794345,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,978440,,7,1,,,Potency,nM,,1613.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,1.6137
14335,,active,6850392,[],CHEMBL1794494,PUBCHEM_BIOASSAY: Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488938],F,,,BAO_0000186,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,5.88,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,,AC50,nM,,1333.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,AC50,uM,UO_0000065,,1.333
14336,,inconclusive,7104842,[],CHEMBL1794580,"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]",F,,,BAO_0000186,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,978440,,7,1,,,Potency,nM,,6424.1,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Potency,uM,UO_0000065,,6.4241
14337,,inconclusive,7551248,[],CHEMBL1794467,PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878],F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1201862,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,978440,,7,1,,,Potency,nM,,39810.7,CHEMBL1795087,Homo sapiens,Ubiquitin carboxyl-terminal hydrolase 1,9606.0,,,Potency,uM,UO_0000065,,39.8107
14338,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731401,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
14339,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731402,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
14340,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731403,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
14341,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731404,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
14342,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731405,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
14343,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731406,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
14344,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731407,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
14345,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731408,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
14346,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731409,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14347,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731410,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14348,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731411,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
14349,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731412,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
14350,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731413,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
14351,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731414,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
14352,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731415,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
14353,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731416,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
14354,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731417,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
14355,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731418,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
14356,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731419,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
14357,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731420,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
14358,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731421,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
14359,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731422,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
14360,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731423,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
14361,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731424,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
14362,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731425,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
14363,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731426,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
14364,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731427,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
14365,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731428,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
14366,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731429,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
14367,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731430,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
14368,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731431,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
14369,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731432,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
14370,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731433,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
14371,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731434,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
14372,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731435,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14373,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731436,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14374,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731437,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14375,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731438,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14376,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731439,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14377,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731440,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14378,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731441,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
14379,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731442,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
14380,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731443,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
14381,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731444,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
14382,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731445,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14383,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731446,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14384,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731447,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14385,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731448,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14386,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731449,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14387,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731450,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14388,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731451,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
14389,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731452,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
14390,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731453,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
14391,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731454,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
14392,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731455,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
14393,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731456,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
14394,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731457,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
14395,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731458,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
14396,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731459,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
14397,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731460,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
14398,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731461,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
14399,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731462,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
14400,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731463,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
14401,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731464,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
14402,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731465,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
14403,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731466,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
14404,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731467,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
14405,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731468,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
14406,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731469,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
14407,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731470,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
14408,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731471,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
14409,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731472,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
14410,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731473,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
14411,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731474,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
14412,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731475,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
14413,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731476,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
14414,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731477,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
14415,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731478,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
14416,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731479,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
14417,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731480,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
14418,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731481,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
14419,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731482,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
14420,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731483,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
14421,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731484,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
14422,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731485,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
14423,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731486,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
14424,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731487,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
14425,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731488,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
14426,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731489,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
14427,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731490,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
14428,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731491,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
14429,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731492,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
14430,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731493,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
14431,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731494,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
14432,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731495,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
14433,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731496,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
14434,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731497,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
14435,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731498,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
14436,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731499,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
14437,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731500,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
14438,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731501,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14439,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731502,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14440,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731503,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14441,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731504,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14442,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731505,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14443,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731506,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14444,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731507,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
14445,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731508,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
14446,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731509,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14447,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731510,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14448,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731511,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14449,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731512,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14450,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731513,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14451,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731514,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14452,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731515,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14453,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731516,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14454,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731517,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
14455,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731518,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
14456,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731519,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
14457,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731520,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
14458,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731521,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
14459,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731522,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
14460,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731523,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
14461,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731524,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
14462,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731525,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14463,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731526,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14464,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731527,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
14465,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731528,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
14466,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7731529,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14467,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733523,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14468,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733524,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14469,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733525,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14470,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733526,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
14471,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733527,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
14472,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733528,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
14473,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733529,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
14474,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733530,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
14475,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733531,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
14476,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733532,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
14477,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733533,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
14478,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733534,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
14479,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733535,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
14480,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733536,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
14481,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733537,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
14482,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733538,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
14483,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733539,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
14484,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733540,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,,,,
14485,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733541,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,,,,
14486,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733542,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
14487,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733543,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
14488,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733544,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
14489,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733545,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
14490,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733546,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
14491,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733547,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
14492,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733548,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
14493,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733549,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
14494,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733550,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
14495,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733551,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
14496,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733552,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
14497,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733553,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
14498,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733554,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14499,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733555,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14500,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733556,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
14501,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733557,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
14502,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733558,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
14503,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733559,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
14504,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733560,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
14505,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733561,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
14506,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733562,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
14507,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733563,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
14508,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733564,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
14509,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733565,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
14510,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733566,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14511,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733567,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14512,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733568,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14513,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733569,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14514,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733570,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14515,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733571,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14516,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733572,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
14517,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733573,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
14518,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733574,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
14519,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733575,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
14520,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733576,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14521,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733577,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14522,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733578,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14523,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733579,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14524,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733580,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
14525,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733581,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
14526,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733582,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
14527,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733583,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
14528,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733584,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
14529,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733585,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
14530,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733586,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
14531,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733587,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
14532,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733588,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,IC50,,,,
14533,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733589,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,Ki,,,,
14534,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733590,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,IC50,,,,
14535,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733591,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,Ki,,,,
14536,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733592,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,IC50,,,,
14537,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733593,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,Ki,,,,
14538,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733594,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,IC50,,,,
14539,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733595,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,Ki,,,,
14540,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733596,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,IC50,,,,
14541,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733597,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,Ki,,,,
14542,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733598,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,IC50,,,,
14543,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733599,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,Ki,,,,
14544,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733600,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,IC50,,,,
14545,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733601,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,Ki,,,,
14546,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733602,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,IC50,,,,
14547,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733603,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,Ki,,,,
14548,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733604,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,IC50,,,,
14549,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733605,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,Ki,,,,
14550,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733606,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,IC50,,,,
14551,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733607,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,Ki,,,,
14552,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733608,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,IC50,,,,
14553,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733609,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,Ki,,,,
14554,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733610,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,IC50,,,,
14555,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733611,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,Ki,,,,
14556,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733612,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,IC50,,,,
14557,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733613,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,Ki,,,,
14558,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733614,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,IC50,,,,
14559,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733615,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,Ki,,,,
14560,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733616,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14561,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733617,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14562,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733618,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,IC50,,,,
14563,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733619,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,Ki,,,,
14564,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733620,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,IC50,,,,
14565,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733621,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,Ki,,,,
14566,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733622,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,IC50,,,,
14567,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733623,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,Ki,,,,
14568,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733624,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,IC50,,,,
14569,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733625,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,Ki,,,,
14570,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733626,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,IC50,,,,
14571,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733627,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,Ki,,,,
14572,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733628,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14573,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733629,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14574,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733630,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,IC50,,,,
14575,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733631,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,Ki,,,,
14576,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733632,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,IC50,,,,
14577,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733633,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,Ki,,,,
14578,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733634,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,IC50,,,,
14579,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733635,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,Ki,,,,
14580,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733636,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,IC50,,,,
14581,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733637,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,Ki,,,,
14582,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733638,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14583,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733639,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14584,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733640,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14585,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733641,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14586,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733642,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,IC50,,,,
14587,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733643,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,Ki,,,,
14588,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733644,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,IC50,,,,
14589,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733645,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,Ki,,,,
14590,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733646,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,IC50,,,,
14591,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733647,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,Ki,,,,
14592,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733648,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000190,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,IC50,,,,
14593,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733649,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000192,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,Ki,,,,
14594,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733650,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
14595,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733651,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
14596,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733652,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,IC50,,,,
14597,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7733653,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000192,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,Ki,,,,
14598,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735678,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,IC50,,,,
14599,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735679,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,Ki,,,,
14600,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735680,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000190,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,IC50,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,IC50,,,,
14601,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7735681,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000192,BAO_0000249,cell membrane format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909046,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1540001,,15,0,,,Ki,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,Ki,,,,
14602,,,7831323,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
14603,,,7831324,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
14604,,,7831325,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
14605,,,7831326,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
14606,,,7831327,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_elevated liver function tests,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,1.0
14607,,,7831328,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_hepatic failure,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,1.0
14608,,,7831329,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_hepatic necrosis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,1.0
14609,,,7831330,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
14610,,,7831331,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_hepatomegaly,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,0.0
14611,,,7831332,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
14612,,,7831333,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
14613,,,7831334,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
14614,,,7831335,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
14615,,,7831336,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1541232,=,1,0,=,,HepSE_Combined Scores,,,5.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,5.0
14616,,Toxic,7844701,[],CHEMBL1912156,Antibacterial activity against Pseudoalteromonas sp. D41 assessed as growth inhibition at 10 uM up to 6 hrs by viability assay,A,,,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909550,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1543262,,1,0,,,GI,,,,CHEMBL612558,,ADMET,,,,GI,,,,
14617,,Toxic,7844704,[],CHEMBL1912158,Antibacterial activity against Paracoccus sp. 4M6 assessed as growth inhibition at 10 uM up to 6 hrs by viability assay,A,,,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1909550,Bioorg Med Chem Lett,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1543262,,1,0,,,GI,,,,CHEMBL612558,,ADMET,,,,GI,,,,
14618,,,7983301,[],CHEMBL1937162,Antibacterial activity against Staphylococcus aureus RN4220 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14619,,,7983327,[],CHEMBL1937163,Antibacterial activity against Staphylococcus aureus KCTC 503 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14620,,,7983353,[],CHEMBL1937164,Antibacterial activity against Escherichia coli CCARM 1924 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14621,,,7983379,[],CHEMBL1937234,Antibacterial activity against Escherichia coli CCARM 1356 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14622,,,7983398,[],CHEMBL1937235,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14623,,,7983417,[],CHEMBL1937236,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14624,,,7983436,[],CHEMBL1937237,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14625,,,7983455,[],CHEMBL1937238,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 20 hrs by twofold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932976,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1569530,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14626,,,7989905,[],CHEMBL1937218,Antibacterial activity against Staphylococcus aureus MTCC 2901 after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14627,,,7989922,[],CHEMBL1937219,Antibacterial activity against Bacillus subtilis MTCC 2063 after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14628,,,7989939,[],CHEMBL1937220,Antibacterial activity against Escherichia coli MTCC 1652 after 24 hrs by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14629,,,7989990,[],CHEMBL1937223,Antibacterial activity against Staphylococcus aureus MTCC 2901 after 24 hrs followed by subculturing,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM/ml,,,0.019
14630,,,7990007,[],CHEMBL1937224,Antibacterial activity against Bacillus subtilis MTCC 2063 after 24 hrs by tube dilution method hrs followed by subculturing,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,uM/ml,,,0.019
14631,,,7990024,[],CHEMBL1937225,Antibacterial activity against Escherichia coli MTCC 1652 after 24 hrs by tube dilution method hrs followed by subculturing,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL1932988,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1568124,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM/ml,,,0.019
14632,,,10861755,[],CHEMBL2026304,Ratio of MIC for wild type Escherichia coli HS414 to MIC for acrB-deficient Escherichia coli HS832 by agar dilution method,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021919,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1637563,=,1,0,=,,Ratio,,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,1.0
14633,,,10861799,[],CHEMBL2026305,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021919,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1637563,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.004
14634,,,10871110,[],CHEMBL2025271,Antibacterial activity against Staphylococcus aureus SA-1199B overexpressing NorA MDR efflux pump after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021901,J Nat Prod,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1638851,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,100.0
14635,,,10871111,[],CHEMBL2025274,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021901,J Nat Prod,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1638851,=,1,1,=,,MIC,nM,,3100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3.1
14636,,,10871112,[],CHEMBL2025462,Antimycobacterial activity against Pseudomonas aeruginosa K1119 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021901,J Nat Prod,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1638851,=,1,1,=,,MIC,nM,,6200.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,6.2
14637,,,10871113,[],CHEMBL2025463,Antimycobacterial activity against Pseudomonas aeruginosa K767 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2021901,J Nat Prod,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1638851,=,1,1,=,,MIC,nM,,6200.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,6.2
14638,,,10891725,[],CHEMBL2032950,Antibacterial activity against Escherichia coli MTCC 443 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14639,,,10891741,[],CHEMBL2032949,Antibacterial activity against Vibrio cholerae MTCC 3906 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14640,,,10891757,[],CHEMBL2032948,Antibacterial activity against Salmonella typhi MTCC 98 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14641,,,10891773,[],CHEMBL2032947,Antibacterial activity against Bacillus subtilis MTCC 441 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14642,,,10891789,[],CHEMBL2032946,Antibacterial activity against Clostridium tetani MTCC 449 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14643,,,10891805,[],CHEMBL2032849,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 by macrobroth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2029281,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1642276,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14644,,,10911373,[],CHEMBL2037875,Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14645,,,10911393,[],CHEMBL2037874,Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14646,,,10911413,[],CHEMBL2037873,Antibacterial activity against Salmonella typhi MTCC 98 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14647,,,10912303,[],CHEMBL2037872,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14648,,,10912323,[],CHEMBL2037871,Antibacterial activity against Clostridium tetani MTCC 449 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14649,,,10912343,[],CHEMBL2037870,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after 24 hrs by micro-broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2034858,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1646728,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14650,,,10919676,[],CHEMBL2043736,Antibacterial activity against Bacillus subtilis MTCC 441 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14651,,,10919706,[],CHEMBL2043737,Antibacterial activity against Clostridium tetani MTCC 449 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14652,,,10919736,[],CHEMBL2043738,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14653,,,10919766,[],CHEMBL2043739,Antibacterial activity against Escherichia coli MTCC 443 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14654,,,10919796,[],CHEMBL2043740,Antibacterial activity against Salmonella typhi MTCC 98 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14655,,,10919826,[],CHEMBL2043831,Antibacterial activity against Vibrio cholerae MTCC 3906 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1648355,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14656,,Not Determined,10919856,[],CHEMBL2043832,Antifungal activity against Aspergillus fumigatus MTCC 3008 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1648355,,1,0,,,MIC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,,,,
14657,,Not Determined,10919886,[],CHEMBL2043833,Antifungal activity against Candida albicans MTCC 227 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040757,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1648355,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
14658,,,10922013,[],CHEMBL2044310,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040785,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1648822,=,1,1,=,,MIC,nM,,9800.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,umol/ml,UO_0000065,,0.0098
14659,,,10922026,[],CHEMBL2044311,Antibacterial activity against Escherichia coli MTCC 7443 after 24 hrs by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040785,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,1648822,=,1,1,=,,MIC,nM,,9800.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,0.0098
14660,,,10929051,[],CHEMBL2045843,Antibacterial activity against Staphylococcus aureus KCTC 4220 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14661,,,10929052,[],CHEMBL2045844,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14662,,,10929053,[],CHEMBL2045845,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14663,,,10929054,[],CHEMBL2045846,Antibacterial activity against Escherichia coli 1356 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14664,,,10929219,[],CHEMBL2045850,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14665,,,10929220,[],CHEMBL2045851,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14666,,,10929221,[],CHEMBL2045852,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14667,,,10929222,[],CHEMBL2045853,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2040848,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1650227,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14668,,,10937243,[],CHEMBL2050345,"Resistance ratio, MIC for methicillin-resistant Staphylococcus aureus ATCC 33592 grown on half-MIC concentration for 3 passages to MIC for methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs",F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2046294,J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1652157,>,1,0,>,,Ratio,,,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,20.0
14669,,,10970873,[],CHEMBL2065486,Antibacterial activity against Escherichia coli MTCC 443,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2062456,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1660745,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14670,,,10970888,[],CHEMBL2065487,Antibacterial activity against Bacillus subtilis MTCC 441,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2062456,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1660745,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14671,,,10970903,[],CHEMBL2065488,Antibacterial activity against Staphylococcus aureus MTCC 96,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2062456,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1660745,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14672,,,10970918,[],CHEMBL2065489,Antibacterial activity against Streptococcus pyogenes MTCC 442,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2062456,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1660745,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14673,,is not an inhibitor [-],11002055,[],CHEMBL2078314,"TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, Norfloxacin: 2000 uM) in Xenopus laevis oocytes",F,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2074574,J Pharmacol Exp Ther,1999.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1671890,,18,0,,,Activity,,,,CHEMBL1777665,Rattus norvegicus,Solute carrier family 22 member 6,10116.0,,,Activity,,,,
14674,,is not an inhibitor [-],11002616,[],CHEMBL2078112,"TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.010? uM, Norfloxacin: 500 uM) in OCTN2-expressing HEK293 cells",F,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2073748,J Pharmacol Exp Ther,1999.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1672480,,18,0,,,Activity,,,,CHEMBL2073693,Homo sapiens,Solute carrier family 22 member 5,9606.0,,,Activity,,,,
14675,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [(at a rough estimate) 290 % of control],11003074,[],CHEMBL2077385,"TP_TRANSPORTER: increase in Doxorubicin intracellular accumulation (Doxorubicin: 5 uM, Norfloxacin: 500 uM) in P388/ADR cells",F,,,BAO_0000375,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2074556,Clin Exp Pharmacol Physiol,2002.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1672759,,18,0,,,Activity,,,,CHEMBL2573,Mus musculus,P-glycoprotein 3,10090.0,,,Activity,,,,
14676,,,11006759,[],CHEMBL2092337,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14677,,,11006825,[],CHEMBL2092336,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14678,,,11006891,[],CHEMBL2092339,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14679,,,11006957,[],CHEMBL2092340,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 clinical isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14680,,,11009109,[],CHEMBL2092341,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 clinical isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14681,,,11009175,[],CHEMBL2092342,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 clinical isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14682,,,11009241,[],CHEMBL2092343,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 clinical isolate after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14683,,,11011490,[],CHEMBL2092338,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2086385,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1676258,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14684,,,12054338,[],CHEMBL2154908,Antibacterial activity against Staphylococcus aureus RN4220 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14685,,,12054355,[],CHEMBL2154907,Antibacterial activity against Staphylococcus aureus KCTC 503 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14686,,,12054372,[],CHEMBL2154909,Antibacterial activity against Escherichia coli CCARM 1924 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14687,,,12054389,[],CHEMBL2154910,Antibacterial activity against Escherichia coli CCARM 1356 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14688,,,12054406,[],CHEMBL2154911,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14689,,,12054423,[],CHEMBL2154912,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14690,,,12055322,[],CHEMBL2154913,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14691,,,12055339,[],CHEMBL2154914,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 20 hrs by two fold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2150942,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732022,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14692,,,12169138,[],CHEMBL2214612,Antimicrobial activity against Eberthella typhosa by microbroth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,4.0
14693,,,12169159,[],CHEMBL2214614,Antimicrobial activity against Bacillus proteus by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,8.0
14694,,,12169180,[],CHEMBL2214615,Antimicrobial activity against Pseudomonas aeruginosa by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
14695,,,12169201,[],CHEMBL2214616,Antimicrobial activity against Shigella dysenteriae by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,4.0
14696,,,12169222,[],CHEMBL2214617,Antimicrobial activity against Escherichia coli DH52 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14697,,,12169243,[],CHEMBL2214618,Antimicrobial activity against Micrococcus luteus ATCC 4698 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
14698,,,12170645,[],CHEMBL2214619,Antimicrobial activity against Bacillus subtilis by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14699,,,12170666,[],CHEMBL2214620,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14700,,,12170687,[],CHEMBL2214621,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203243,Eur J Med Chem,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1756372,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14701,,,12189133,[],CHEMBL2212329,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14702,,,12189178,[],CHEMBL2212330,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14703,,,12189223,[],CHEMBL2212331,Antibacterial activity against multidrug-resistant Staphylococcus aureus CCARM 3506 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14704,,,12189268,[],CHEMBL2212332,Antibacterial activity against multidrug-resistant Staphylococcus aureus CCARM 3167 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14705,,,12189920,[],CHEMBL2212333,Antibacterial activity against Escherichia coli 1356 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14706,,,12189970,[],CHEMBL2212334,Antibacterial activity against Staphylococcus aureus KCTC 503 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14707,,,12190020,[],CHEMBL2212335,Antibacterial activity against Staphylococcus aureus KCTC 209 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14708,,,12190070,[],CHEMBL2212336,Antibacterial activity against Staphylococcus aureus RN 4220 incubated for 24 hrs serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2203015,Bioorg Med Chem Lett,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1759371,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14709,,,12391288,[],CHEMBL3063018,Antibacterial activity against Staphylococcus aureus at 50 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,30.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,30.45
14710,,,12391297,[],CHEMBL3063019,Antibacterial activity against Pseudomonas aeruginosa at 200 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.11,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,31.11
14711,,,12391306,[],CHEMBL3063020,Antibacterial activity against Pseudomonas aeruginosa at 100 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.11,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,31.11
14712,,,12391315,[],CHEMBL3063021,Antibacterial activity against Pseudomonas aeruginosa at 50 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.11,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,31.11
14713,,,12391324,[],CHEMBL3063023,Antibacterial activity against Escherichia coli at 200 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,35.53,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,35.53
14714,,,12391333,[],CHEMBL3063022,Antibacterial activity against Escherichia coli at 100 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,35.42,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,35.42
14715,,,12391342,[],CHEMBL3063024,Antibacterial activity against Escherichia coli at 50 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,35.43,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,35.43
14716,,,12392276,[],CHEMBL3048725,Antifungal activity against Aspergillus niger ATCC 9029 after 7 days by agar plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046874,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1794747,=,1,1,=,,IZ,mm,,0.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,DIZ,mm,UO_0000016,,0.0
14717,,,12392303,[],CHEMBL3050333,Antibacterial activity against Proteus vulgaris ATCC 29905 after 24 hr by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046874,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1794747,=,1,1,=,,IZ,mm,,21.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,IZ,mm,UO_0000016,,21.0
14718,,,12392330,[],CHEMBL3050334,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hr by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046874,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1794747,=,1,1,=,,IZ,mm,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,20.0
14719,,,12392357,[],CHEMBL3050336,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hr by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046874,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1794747,=,1,1,=,,IZ,mm,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,19.0
14720,,,12392384,[],CHEMBL3050335,Antibacterial activity against Bacillus megaterium ATCC 14518 after 24 hr by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046874,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1794747,=,1,1,=,,IZ,mm,,23.0,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,IZ,mm,UO_0000016,,23.0
14721,,,12392413,[],CHEMBL3050339,Antibacterial activity against Escherichia coli MTCC 42 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045029,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1795290,=,1,0,=,,-logMIC,,,2.698,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.698
14722,,,12392426,[],CHEMBL3050340,Antibacterial activity against Staphylococcus aureus MTCC 7443 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045029,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1795290,=,1,0,=,,-logMIC,,,2.698,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.698
14723,,,12392439,[],CHEMBL3050341,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045029,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1795290,=,1,0,=,,-logMIC,,,2.698,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.698
14724,,Not Determined,12393997,[],CHEMBL3048833,Antifungal activity against Candida albicans MTCC 227 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1795300,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
14725,,Not Determined,12393998,[],CHEMBL3048834,Antifungal activity against Aspergillus fumigatus MTCC 3008 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1795300,,1,0,,,MIC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,,,,
14726,,,12394046,[],CHEMBL3048835,Antibacterial activity against Escherichia coli MTCC 443 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14727,,,12394065,[],CHEMBL3048836,Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14728,,,12394084,[],CHEMBL3048837,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14729,,,12394103,[],CHEMBL3048838,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14730,,,12394122,[],CHEMBL3048839,Antibacterial activity against Clostridium tetani MTCC 449 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14731,,,12394141,[],CHEMBL3048840,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045821,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795300,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14732,,,12396141,[],CHEMBL3062941,Bactericidal activity against Escherichia coli MTCC 1652,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM/ml,,,0.019
14733,,,12396159,[],CHEMBL3062943,Bactericidal activity against Bacillus subtilis MTCC 2063,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,uM/ml,,,0.019
14734,,,12396177,[],CHEMBL3062942,Bactericidal activity against Staphylococcus aureus MTCC 2901,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM/ml,,,0.019
14735,,,12396231,[],CHEMBL3062946,Antibacterial activity against Escherichia coli MTCC 1652 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14736,,,12396249,[],CHEMBL3062947,Antibacterial activity against Bacillus subtilis MTCC 2063 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14737,,,12396267,[],CHEMBL3062948,Antibacterial activity against Staphylococcus aureus MTCC 2901 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046140,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1799053,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14738,,,12399448,[],CHEMBL3061970,Antibacterial activity against Micrococcus luteus MTCC 1538 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,32.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,32.0
14739,,,12399472,[],CHEMBL3061995,Antibacterial activity against Staphylococcus aureus MTCC 1430 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,28.0
14740,,,12399473,[],CHEMBL3061135,Antibacterial activity against Pseudomonas fluorescens MTCC 2421 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,27.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,DIZ,mm,UO_0000016,,27.0
14741,,,12399474,[],CHEMBL3061142,Antibacterial activity against Escherichia coli MTCC 1573 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,27.0
14742,,,12399475,[],CHEMBL3061988,Antibacterial activity against Bacillus pumilus MTCC 1456 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,27.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,DIZ,mm,UO_0000016,,27.0
14743,,,12399484,[],CHEMBL3062002,Antibacterial activity against Bacillus subtilis MTCC 441 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,25.0
14744,,,12399491,[],CHEMBL3061948,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 at 10 ug/ml after 48 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044945,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1795982,=,1,1,=,,IZ,mm,,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,24.0
14745,,,12401422,[],CHEMBL3047094,Antibacterial activity against Klebsiella pneumoniae after 24 hr by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046348,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1799523,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
14746,,,12401435,[],CHEMBL3047095,Antibacterial activity against Escherichia coli after 24 hr by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046348,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1799523,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
14747,,,12401448,[],CHEMBL3047096,Antibacterial activity against Bacillus subtilis after 24 hr by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046348,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1799523,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,16.0
14748,,,12401938,[],CHEMBL3068579,Antibacterial activity against Streptococcus pyogenes by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045610,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795854,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,10.0
14749,,,12401964,[],CHEMBL3068580,Antibacterial activity against Staphylococcus aureus by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045610,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795854,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
14750,,,12401990,[],CHEMBL3068581,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045610,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795854,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
14751,,,12402016,[],CHEMBL3068582,Antibacterial activity against Escherichia coli by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045610,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1795854,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14752,,,12406175,[],CHEMBL3049077,Bactericidal activity against Klebsiella pneumoniae wound isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,50.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,mg/L,,,50.0
14753,,,12406185,[],CHEMBL3049078,Bactericidal activity against Klebsiella pneumoniae urine isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,11.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,mg/L,,,11.5
14754,,,12406195,[],CHEMBL3049079,Bactericidal activity against Pseudomonas aeruginosa wound isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,25.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,mg/L,,,25.8
14755,,,12406205,[],CHEMBL3050396,Bactericidal activity against Pseudomonas aeruginosa urine isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,13.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,mg/L,,,13.7
14756,,,12406215,[],CHEMBL3050397,Bactericidal activity against Staphylococcus saprophyticus bronchi isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,50.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MBC,mg/L,,,50.0
14757,,,12406225,[],CHEMBL3050398,Bactericidal activity against Staphylococcus epidermidis eye isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,75.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,mg/L,,,75.0
14758,,,12406235,[],CHEMBL3052133,Bactericidal activity against Staphylococcus aureus urine isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,11.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,11.5
14759,,,12406245,[],CHEMBL3047133,Bactericidal activity against Staphylococcus aureus wound isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,9.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,mg/L,,,9.8
14760,,,12406255,[],CHEMBL3047134,Bactericidal activity against Escherichia coli bronchi isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,12.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,mg/L,,,12.2
14761,,,12406265,[],CHEMBL3047135,Bactericidal activity against Escherichia coli urine isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,7.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,mg/L,,,7.3
14762,,,12406275,[],CHEMBL3047136,Bactericidal activity against multidrug-resistant Acinetobacter baumannii urine isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,62.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MBC,mg/L,,,62.5
14763,,,12406285,[],CHEMBL3047137,Bactericidal activity against multidrug-resistant Acinetobacter baumannii wound isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,41.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MBC,mg/L,,,41.7
14764,,,12406295,[],CHEMBL3047138,Bactericidal activity against multidrug-resistant Acinetobacter baumannii bronchi isolate after 24 hr by NCCLS dilution tube method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046735,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1794780,=,1,0,=,,MBC,mg/L,,37.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MBC,mg/L,,,37.5
14765,,,12406727,[],CHEMBL3047604,Antibacterial activity against Streptococcus pyogenes MTCC 442 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14766,,,12406743,[],CHEMBL3047605,Antibacterial activity against Staphylococcus aureus MTCC 96 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14767,,,12406759,[],CHEMBL3047606,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhimurium MTCC 98 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14768,,,12406775,[],CHEMBL3047607,Antibacterial activity against Klebsiella pneumoniae MTCC 109 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14769,,,12406791,[],CHEMBL3047608,Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14770,,,12406807,[],CHEMBL3062974,Antibacterial activity against Escherichia coli MTCC 443 after overnight incubation by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045851,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1796476,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14771,,,12411492,[],CHEMBL3046982,Antimicrobial activity against Vibrio cholerae MTCC 3906 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14772,,,12411513,[],CHEMBL3061413,Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,10.0
14773,,,12412416,[],CHEMBL3048069,Antimicrobial activity against Staphylococcus aureus after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046007,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1796985,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14774,,,12412437,[],CHEMBL3048070,Antimicrobial activity against Bacillus subtilis after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046007,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1796985,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14775,,,12415362,[],CHEMBL3068438,Antimicrobial activity against Escherichia coli MTCC 739 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046879,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1797426,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14776,,,12415389,[],CHEMBL3068439,Antimicrobial activity against Bacillus subtilis MTCC 2423 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046879,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1797426,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14777,,,12415416,[],CHEMBL3068440,Antimicrobial activity against Staphylococcus aureus MTCC 1430 after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046879,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1797426,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14778,,,12417546,[],CHEMBL3063013,Antibacterial activity against Bacillus subtilis at 200 ug/ml after 24 hr by agar diffusion cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.34,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,31.34
14779,,,12417555,[],CHEMBL3063014,Antibacterial activity against Bacillus subtilis at 100 ug/ml after 24 hr by agar diffusion cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.34,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,31.34
14780,,,12417564,[],CHEMBL3063015,Antibacterial activity against Bacillus subtilis at 50 ug/ml after 24 hr by agar diffusion cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,31.34,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,31.34
14781,,,12417573,[],CHEMBL3063016,Antibacterial activity against Staphylococcus aureus at 200 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,30.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,30.45
14782,,,12417582,[],CHEMBL3063017,Antibacterial activity against Staphylococcus aureus at 100 ug/ml after 24 hr by agar diffusion cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045717,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1798834,=,1,1,=,,IZ,mm,,30.45,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,30.45
14783,,,12419369,[],CHEMBL3048068,Antimicrobial activity against Escherichia coli after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046007,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1796985,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14784,,,12420006,[],CHEMBL3061414,Antimicrobial activity against Escherichia coli MTCC 443 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14785,,,12420027,[],CHEMBL3061415,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14786,,,12420048,[],CHEMBL3061416,Antimicrobial activity against Clostridium tetani MTCC 449 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14787,,,12420069,[],CHEMBL3061417,Antimicrobial activity against Bacillus subtilis MTCC 441 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045502,Med Chem Res,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1794313,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14788,,,12432161,[],CHEMBL3066823,"Apparent hydrophobicity, log D of the compound in Octanol-buffer",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1803025,=,1,1,=,,LogD,,,-2.42,CHEMBL2362975,,No relevant target,,,,logD(app),,,,-2.42
14789,,,12432215,[],CHEMBL3066822,"Dissociation constant, pKa of the compound at pH 7.3",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1803025,=,1,0,=,,pKa,,,2.08,CHEMBL2362975,,No relevant target,,,,pKa,,,,2.08
14790,,,12432269,[],CHEMBL3066824,Apparent permeability of the compound by PAMPA,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1803025,=,1,0,=,,logPapp,,,-6.71,CHEMBL2362975,,No relevant target,,,,logPapp,,,,-6.71
14791,,,12432343,[],CHEMBL3066825,"Hydrophobicity, log P of the compound in octanol-water by shaking-flask method",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046441,J Agric Food Chem,2011.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1803025,=,1,1,=,,LogP,,,-1.03,CHEMBL2362975,,No relevant target,,,,logP,,,,-1.03
14792,,,12454614,[],CHEMBL3054949,Antibacterial activity against Streptococcus pyogenes by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046517,Med Chem Res,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805886,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,10.0
14793,,,12454652,[],CHEMBL3054950,Antibacterial activity against Staphylococcus aureus by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046517,Med Chem Res,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805886,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
14794,,,12454690,[],CHEMBL3056005,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046517,Med Chem Res,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805886,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
14795,,,12455996,[],CHEMBL3063315,Antibacterial activity against Escherichia coli after 24 hr by serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046853,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810830,=,1,0,=,,-logMIC,,,3.33,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,3.33
14796,,,12456025,[],CHEMBL3063316,Antibacterial activity against Bacillus subtilis after 24 hr by serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046853,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810830,=,1,0,=,,-logMIC,,,3.33,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,3.33
14797,,,12456054,[],CHEMBL3063317,Antibacterial activity against Staphylococcus aureus after 24 hr by serial dilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046853,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810830,=,1,0,=,,-logMIC,,,3.33,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,3.33
14798,,,12457422,[],CHEMBL3056006,Antibacterial activity against Escherichia coli by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046517,Med Chem Res,2010.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805886,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14799,,,12459119,[],CHEMBL3055911,Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14800,,,12459136,[],CHEMBL3055912,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14801,,,12459153,[],CHEMBL3055913,Antibacterial activity against Escherichia coli MTCC 443 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14802,,,12460713,[],CHEMBL3055914,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14803,,,12460730,[],CHEMBL3064218,Antibacterial activity against Clostridium tetani MTCC 449 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14804,,,12460747,[],CHEMBL3064219,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046743,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805184,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14805,,,12462690,[],CHEMBL3058393,Antibacterial activity against Escherichia coli MTCC 1573 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,50.0
14806,,,12462691,[],CHEMBL3058895,Antibacterial activity against Pseudomonas fluorescens MTCC 2421 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,50.0
14807,,,12462692,[],CHEMBL3058896,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,50.0
14808,,,12462693,[],CHEMBL3058897,Antibacterial activity against Micrococcus luteus MTCC 1538 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,50.0
14809,,,12462694,[],CHEMBL3058898,Antibacterial activity against Bacillus pumilus MTCC 1456 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,MIC,ug ml-1,UO_0000274,,50.0
14810,,,12462695,[],CHEMBL3058900,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,50.0
14811,,,12462696,[],CHEMBL3058899,Antibacterial activity against Staphylococcus aureus MTCC 1430 after 24 hr by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805608,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
14812,,,12463450,[],CHEMBL3054328,Antibacterial activity against Escherichia coli MTCC 40 after 24 hr by cup-plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046258,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805325,=,1,1,=,,MIC,ug.mL-1,,8.46,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.46
14813,,,12463470,[],CHEMBL3054329,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 after 24 hr by cup-plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046258,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805325,=,1,1,=,,MIC,ug.mL-1,,10.98,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.98
14814,,,12463490,[],CHEMBL3054844,Antibacterial activity against Bacillus subtilis MTCC 619 after 24 hr by cup-plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046258,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805325,=,1,1,=,,MIC,ug.mL-1,,16.62,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,16.62
14815,,,12463510,[],CHEMBL3054845,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hr by cup-plate method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046258,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805325,=,1,1,=,,MIC,ug.mL-1,,4.43,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.43
14816,,,12464287,[],CHEMBL3058932,Antibacterial activity against Escherichia coli MTCC 1573 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,36.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,36.0
14817,,,12464288,[],CHEMBL3058933,Antibacterial activity against Pseudomonas fluorescens MTCC 2421 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,25.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,DIZ,mm,UO_0000016,,25.0
14818,,,12464289,[],CHEMBL3056390,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,28.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,28.0
14819,,,12464290,[],CHEMBL3056918,Antibacterial activity against Micrococcus luteus MTCC 1538 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,26.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,26.0
14820,,,12464291,[],CHEMBL3056923,Antibacterial activity against Bacillus pumilus MTCC 1456 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,28.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,DIZ,mm,UO_0000016,,28.0
14821,,,12464292,[],CHEMBL3056928,Antibacterial activity against Bacillus subtilis MTCC 441 at 100 ug/ml after 18 hr by cup plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,23.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,23.0
14822,,,12464293,[],CHEMBL3056933,Antibacterial activity against Staphylococcus aureus MTCC 1430 at 100 ug/ml after 18 hr by cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045835,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805608,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,25.0
14823,,,12465311,[],CHEMBL3055289,Antibacterial activity against Escherichia coli MTCC 40 by liquid dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045957,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805362,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
14824,,,12465332,[],CHEMBL3055290,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 by liquid dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045957,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805362,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
14825,,,12465353,[],CHEMBL3055291,Antibacterial activity against Bacillus subtilis MTCC 619 by liquid dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045957,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805362,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,5.0
14826,,,12465374,[],CHEMBL3055292,Antibacterial activity against Staphylococcus aureus MTCC 96 by liquid dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045957,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1805362,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,6.0
14827,,,12465437,[],CHEMBL3056301,Antibacterial activity against Staphylococcus aureus after 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046701,Med Chem Res,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805394,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,22.0
14828,,,12465438,[],CHEMBL3056303,Antibacterial activity against Bacillus subtilis after 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046701,Med Chem Res,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805394,=,1,1,=,,IZ,mm,,22.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,22.0
14829,,,12465439,[],CHEMBL3056304,Antibacterial activity against Escherichia coli after 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046701,Med Chem Res,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805394,=,1,1,=,,IZ,mm,,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,22.0
14830,,,12465440,[],CHEMBL3056305,Antibacterial activity against Klebsiella pneumoniae after 24 hr by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046701,Med Chem Res,2007.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1805394,=,1,1,=,,IZ,mm,,22.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IZ,mm,UO_0000016,,22.0
14831,,,12469777,[],CHEMBL3057410,Antimicrobial activity against Clostridium tetani MTCC 449 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14832,,,12469806,[],CHEMBL3057411,Antimicrobial activity against Bacillus subtilis MTCC 441 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14833,,,12469835,[],CHEMBL3057412,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14834,,,12469864,[],CHEMBL3057413,Antimicrobial activity against Vibrio cholerae MTCC 3906 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14835,,,12469893,[],CHEMBL3057414,Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14836,,,12469922,[],CHEMBL3057415,Antimicrobial activity against Escherichia coli MTCC 443 after 24 to 48 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044649,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1806445,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14837,,,12472484,[],CHEMBL3058384,Antibacterial activity against Escherichia coli at 50 mg/well after 24 hr by agar well diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046545,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808027,=,1,1,=,,IZ,mm,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,25.0
14838,,,12472511,[],CHEMBL3058394,Antibacterial activity against Streptococcus pyogenes at 50 mg/well after 24 hr by agar well diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046545,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808027,=,1,1,=,,IZ,mm,,26.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,26.0
14839,,,12472538,[],CHEMBL3058395,Antibacterial activity against Bacillus subtilis at 50 mg/well after 24 hr by agar well diffusion assay,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046545,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808027,=,1,1,=,,IZ,mm,,19.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,19.0
14840,,,12475185,[],CHEMBL3053581,Antimicrobial activity against Escherichia coli after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044730,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1807318,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14841,,,12475204,[],CHEMBL3053582,Antimicrobial activity against Staphylococcus aureus after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044730,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1807318,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14842,,,12475223,[],CHEMBL3053583,Antimicrobial activity against Bacillus subtilis after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044730,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1807318,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14843,,,12477714,[],CHEMBL3056533,Antibacterial activity against Paracoccus denitrificans at 4 ug/ml after 24 hr by agar cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044582,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808485,=,1,1,=,,IZ,mm,,13.0,CHEMBL612495,Paracoccus denitrificans,Paracoccus denitrificans,266.0,,,DIZ,mm,UO_0000016,,13.0
14844,,,12477725,[],CHEMBL3056535,Antibacterial activity against Pseudomonas syringae at 4 ug/ml after 24 hr by agar cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044582,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808485,>,1,1,>,,IZ,mm,,21.0,CHEMBL613025,Pseudomonas syringae,Pseudomonas syringae,317.0,,,DIZ,mm,UO_0000016,,21.0
14845,,,12477736,[],CHEMBL3056004,Antibacterial activity against Enterobacter aerogenes at 4 ug/ml after 24 hr by agar cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044582,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808485,>,1,1,>,,IZ,mm,,21.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,DIZ,mm,UO_0000016,,21.0
14846,,,12477747,[],CHEMBL3055181,Antibacterial activity against Bacillus subtilis at 4 ug/ml after 24 hr by agar cup-plate method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044582,Med Chem Res,2008.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1808485,>,1,1,>,,IZ,mm,,21.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,21.0
14847,,,12481022,[],CHEMBL3062802,Antimicrobial activity against Escherichia coli after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045530,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1808732,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14848,,,12481036,[],CHEMBL3062803,Antimicrobial activity against Staphylococcus aureus after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045530,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1808732,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14849,,,12481050,[],CHEMBL3062804,Antimicrobial activity against Bacillus subtilis after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045530,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1808732,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14850,,,12482304,[],CHEMBL3058953,Antimicrobial activity against Escherichia coli after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045401,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810450,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14851,,,12482342,[],CHEMBL3058954,Antimicrobial activity against Staphylococcus aureus after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045401,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810450,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14852,,,12482380,[],CHEMBL3058955,Antimicrobial activity against Bacillus subtilis after 24 hr by serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045401,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1810450,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14853,,,12483816,[],CHEMBL3056540,Bactericidal activity against Escherichia coli MTCC 1652,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM/ml,,,0.019
14854,,,12483835,[],CHEMBL3056541,Bactericidal activity against Bacillus subtilis MTCC 2063,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,uM/ml,,,0.019
14855,,,12483854,[],CHEMBL3056543,Bactericidal activity against Staphylococcus aureus MTCC 2901,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM/ml,,,0.019
14856,,,12483911,[],CHEMBL3056545,Antibacterial activity against Escherichia coli MTCC 1652 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14857,,,12483930,[],CHEMBL3056546,Antibacterial activity against Bacillus subtilis MTCC 2063 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14858,,,12483949,[],CHEMBL3056547,Antibacterial activity against Staphylococcus aureus MTCC 2901 after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045260,Med Chem Res,2012.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1806066,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14859,,,12528614,[],CHEMBL3078233,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824344,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
14860,,,12528615,[],CHEMBL3078235,Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824344,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14861,,,12528616,[],CHEMBL3078234,Antibacterial activity against Streptococcus pyogenes MTCC 442 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824344,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,10.0
14862,,,12528617,[],CHEMBL3078236,Antibacterial activity against Staphylococcus aureus MTCC 96 after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824344,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
14863,,,12528618,[],CHEMBL3078237,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 at 250 ug/ml after 24 hrs by Kirby-Bauer method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1824344,=,1,1,=,,IZ,mm,,23.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,23.0
14864,,,12528619,[],CHEMBL3078238,Antibacterial activity against Escherichia coli MTCC 443 at 250 ug/ml after 24 hrs by Kirby-Bauer method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1824344,=,1,1,=,,IZ,mm,,29.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,29.0
14865,,,12528620,[],CHEMBL3078239,Antibacterial activity against Streptococcus pyogenes MTCC 442 at 250 ug/ml after 24 hrs by Kirby-Bauer method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1824344,=,1,1,=,,IZ,mm,,21.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,,21.0
14866,,,12528621,[],CHEMBL3078240,Antibacterial activity against Staphylococcus aureus MTCC 96 at 250 ug/ml after 24 hrs by Kirby-Bauer method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044741,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1824344,=,1,1,=,,IZ,mm,,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,28.0
14867,,,12530585,[],CHEMBL3078219,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
14868,,,12530607,[],CHEMBL3078220,Antimicrobial activity against Escherichia coli ATCC 10536 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14869,,,12530629,[],CHEMBL3077162,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
14870,,,12531118,[],CHEMBL3077690,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.39
14871,,,12531131,[],CHEMBL3077691,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.56
14872,,,12531142,[],CHEMBL3077695,Antibacterial activity against Escherichia coli ATCC 8739 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.195
14873,,,12531155,[],CHEMBL3077692,Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,0.195,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,0.195
14874,,,12531168,[],CHEMBL3077693,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.39
14875,,,12531181,[],CHEMBL3077694,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046802,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824526,=,1,1,=,,MIC,ug.mL-1,,0.39,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.39
14876,,,12531838,[],CHEMBL3077163,Antimicrobial activity against Bacillus subtilis ATCC 60511 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14877,,,12531860,[],CHEMBL3077164,Antimicrobial activity against Staphylococcus faecalis ATCC 14506 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,5.0
14878,,,12531882,[],CHEMBL3077165,Antimicrobial activity against Staphylococcus aureus ATCC 11632 assessed as growth inhibition after 24 hr by broth dilution assay method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045230,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825747,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
14879,,,12532094,[],CHEMBL3077737,Antitubercular activity against Mycobacterium tuberculosis,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046014,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825949,=,1,1,=,,IC50,ug.mL-1,,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,ug ml-1,UO_0000274,,8.0
14880,,,12536729,[],CHEMBL3077113,Antibacterial activity against Pseudomonas aeruginosa after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,>,1,1,>,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
14881,,,12536772,[],CHEMBL3077112,Antibacterial activity against Escherichia coli after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14882,,,12536815,[],CHEMBL3077064,Antibacterial activity against Klebsiella pneumoniae after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
14883,,,12536858,[],CHEMBL3077063,Antibacterial activity against Bacillus subtilis after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14884,,,12536901,[],CHEMBL3077062,Antibacterial activity against Enterococcus faecalis after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,<,1,1,<,,MIC,ug.mL-1,,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,5.0
14885,,,12536944,[],CHEMBL3077061,Antibacterial activity against Staphylococcus aureus after 18 hr by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046206,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1823671,<,1,1,<,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
14886,,,12540943,[],CHEMBL3077363,Antibacterial activity against Escherichia coli MTCC 443 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14887,,,12540972,[],CHEMBL3077364,Antibacterial activity against Vibrio cholerae MTCC 3906 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14888,,,12541001,[],CHEMBL3077365,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14889,,,12541963,[],CHEMBL3077366,Antibacterial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14890,,,12541992,[],CHEMBL3077367,Antibacterial activity against Clostridium tetani MTCC 449 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14891,,,12542021,[],CHEMBL3052557,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046070,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1826079,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14892,,,12542367,[],CHEMBL3077930,Antibacterial activity against Escherichia coli MTCC 1089 assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045188,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824939,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
14893,,,12542383,[],CHEMBL3077931,Antibacterial activity against Pseudomonas aeruginosa ATCC 25619 assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045188,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824939,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
14894,,,12542399,[],CHEMBL3077932,Antibacterial activity against Corynebacterium ATCC 29355 assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045188,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824939,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613080,Corynebacterium,Corynebacterium,1716.0,,,MIC,ug ml-1,UO_0000274,,2.0
14895,,,12542415,[],CHEMBL3078419,Antibacterial activity against Staphylococcus aureus ATCC 25365 assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045188,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1824939,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14896,,,12544834,[],CHEMBL3077451,Antibacterial activity against Bacillus subtilis assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046572,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825225,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
14897,,,12544848,[],CHEMBL3077452,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046572,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825225,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14898,,,12544862,[],CHEMBL3077453,Antibacterial activity against Escherichia coli assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046572,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825225,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14899,,,12544876,[],CHEMBL3077454,Antibacterial activity against Vibrio cholerae assessed as growth inhibition after 18 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046572,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825225,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,1.0
14900,,,12578965,[],CHEMBL3074729,Antimicrobial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14901,,,12578979,[],CHEMBL3074730,Antimicrobial activity against Streptococcus pyogenes MTCC 442 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14902,,,12578993,[],CHEMBL3074731,Antimicrobial activity against Staphylococcus aureus MTCC 96 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14903,,,12579007,[],CHEMBL3074732,Antimicrobial activity against Klebsiella pneumoniae MTCC 109 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14904,,,12579021,[],CHEMBL3074733,Antimicrobial activity against Pseudomonas aeruginosa MTCC 1688 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14905,,,12579035,[],CHEMBL3074734,Antimicrobial activity against Escherichia coli MTCC 443 assessed as growth inhibition by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044829,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1840286,<=,1,0,<=,,MIC99,ug ml-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14906,,,12579447,[],CHEMBL3070213,Antibacterial activity against quinolene-resistant Staphylococcus aureus CCARM 3519 clinical isolate assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14907,,,12579460,[],CHEMBL3070214,Antibacterial activity against quinolene-resistant Staphylococcus aureus CCARM 3505 clinical isolate assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14908,,,12579472,[],CHEMBL3070215,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 clinical isolate assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14909,,,12579485,[],CHEMBL3070216,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 clinical isolate assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14910,,,12579498,[],CHEMBL3070217,Antibacterial activity against Escherichia coli CCARM 1356 assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14911,,,12579526,[],CHEMBL3070218,Antibacterial activity against Escherichia coli CCARM 1924 assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14912,,,12579554,[],CHEMBL3070219,Antibacterial activity against Staphylococcus aureus KCTC 503 assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14913,,,12579582,[],CHEMBL3070220,Antibacterial activity against Staphylococcus aureus subsp. aureus RN4220 assessed as growth inhibition after 20 hr by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3044662,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836952,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
14914,,,12583242,[],CHEMBL3074100,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
14915,,,12583266,[],CHEMBL3073626,Antibacterial activity against Escherichia coli ATCC 10536 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14916,,,12583290,[],CHEMBL3073627,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
14917,,,12583314,[],CHEMBL3073628,Antibacterial activity against Bacillus subtilis ATCC 60511 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14918,,,12583338,[],CHEMBL3073630,Antibacterial activity against Enterococcus faecalis ATCC 14506 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,5.0
14919,,,12583397,[],CHEMBL3073913,Antibacterial activity against Salmonella enterica typhimurium MTCC 98 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046207,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1835994,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,10.0
14920,,,12583398,[],CHEMBL3073912,Antibacterial activity against Escherichia coli MTCC 443 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046207,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1835994,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14921,,,12583399,[],CHEMBL3073911,Antibacterial activity against Staphylococcus aureus MTCC 96 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046207,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1835994,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
14922,,,12583400,[],CHEMBL3073910,Antibacterial activity against Bacillus subtilis MTCC 441 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046207,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1835994,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14923,,,12583958,[],CHEMBL3073629,Antibacterial activity against Staphylococcus aureus ATCC 11632 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046455,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837777,<=,1,1,<=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
14924,,Not Determined,12585564,[],CHEMBL3071362,Antifungal activity against Aspergillus niger ATCC 64958 after 16 to 18 hr by Kirby-Bauer disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836766,,1,0,,,MIC,,,,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,,,,
14925,,Not Determined,12585575,[],CHEMBL3073607,Antifungal activity against Candida albicans ATCC 66027 after 16 to 18 hr by Kirby-Bauer disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836766,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
14926,,,12585586,[],CHEMBL3073608,Antibacterial activity against Bacillus subtilis ATCC 11774 after 16 to 18 hr by Kirby-Bauer disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836766,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,10.0
14927,,,12585597,[],CHEMBL3073609,Antibacterial activity against Streptococcus pyogenes ATCC 12384 after 16 to 18 hr by Kirby-Bauer disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836766,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,10.0
14928,,,12585608,[],CHEMBL3073610,Antibacterial activity against Pseudomonas aeruginosa ATCC 25619 after 16 to 18 hr by Kirby-Bauer disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836766,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
14929,,,12585619,[],CHEMBL3073611,Antibacterial activity against Escherichia coli ATCC 25922 after 16 to 18 hr by Kirby-Bauer disc diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045705,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1836766,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14930,,,12592186,[],CHEMBL3074034,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,5.0
14931,,,12592215,[],CHEMBL3074035,Antimicrobial activity against Escherichia coli ATCC 10536 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
14932,,,12592244,[],CHEMBL3074036,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
14933,,,12592273,[],CHEMBL3074037,Antimicrobial activity against Bacillus subtilis ATCC 60511 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14934,,,12592302,[],CHEMBL3074038,Antimicrobial activity against Enterococcus faecalis ATCC 14506 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,5.0
14935,,,12592331,[],CHEMBL3074039,Antimicrobial activity against Staphylococcus aureus ATCC 11632 assessed as growth inhibition after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046035,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837216,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
14936,,,12596102,[],CHEMBL3070890,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.5
14937,,,12596103,[],CHEMBL3070889,Antibacterial activity against Micrococcus luteus MTCC 1538 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.5
14938,,,12596104,[],CHEMBL3070891,Antibacterial activity against Pseudomonas fluorescens MTCC 2421 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,2.5
14939,,,12596105,[],CHEMBL3070893,Antibacterial activity against Bacillus pumilus MTCC 1456 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,MIC,ug ml-1,UO_0000274,,1.25
14940,,,12596106,[],CHEMBL3070894,Antibacterial activity against Staphylococcus aureus MTCC 1430 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.0
14941,,,12596107,[],CHEMBL3070895,Antibacterial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837844,=,1,1,=,,MIC,ug.mL-1,,2.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.5
14942,,,12596108,[],CHEMBL3073429,Antibacterial activity against Pseudomonas fluorescens MTCC 2421 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,27.0,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,DIZ,mm,UO_0000016,,27.0
14943,,,12596109,[],CHEMBL3076285,Antibacterial activity against Escherichia coli MTCC 1573 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,25.0
14944,,,12596110,[],CHEMBL3076292,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,26.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,26.0
14945,,,12596111,[],CHEMBL3074316,Antibacterial activity against Micrococcus luteus MTCC 1538 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,24.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,DIZ,mm,UO_0000016,,24.0
14946,,,12596112,[],CHEMBL3073533,Antibacterial activity against Bacillus pumilus MTCC 1456 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,30.0,CHEMBL612429,Bacillus pumilus,Bacillus pumilus,1408.0,,,DIZ,mm,UO_0000016,,30.0
14947,,,12596113,[],CHEMBL3073995,Antibacterial activity against Staphylococcus aureus MTCC 1430 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,22.0
14948,,,12596114,[],CHEMBL3072613,Antibacterial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition at 10 ug/mL after 48 hr by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046001,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,1837844,=,1,1,=,,IZ,mm,,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,25.0
14949,,Not Determined,12596734,[],CHEMBL3075698,Antifungal activity against Candida albicans MTCC 227 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1839604,,1,0,,,MIC99,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC99,,,,
14950,,Not Determined,12596762,[],CHEMBL3075699,Antifungal activity against Aspergillus fumigatus MTCC 3008 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1839604,,1,0,,,MIC99,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC99,,,,
14951,,,12596790,[],CHEMBL3075700,Antibacterial activity against Vibrio cholerae MTCC 3906 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14952,,,12596818,[],CHEMBL3075701,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14953,,,12597715,[],CHEMBL3075702,Antibacterial activity against Escherichia coli MTCC 443 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14954,,,12597743,[],CHEMBL3075704,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC99,ug ml-1,UO_0000274,,10.0
14955,,,12597771,[],CHEMBL3075703,Antibacterial activity against Clostridium tetani MTCC 449 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC99,ug ml-1,UO_0000274,,50.0
14956,,,12597799,[],CHEMBL3075705,Antibacterial activity against Bacillus subtilis MTCC 441 after overnight incubation by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046907,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1839604,=,1,0,=,,MIC99,ug ml-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC99,ug ml-1,UO_0000274,,100.0
14957,,Not Determined,12598167,[],CHEMBL3069623,Antimicrobial activity against Candida albicans MTCC 227 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1838736,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
14958,,Not Determined,12598197,[],CHEMBL3069624,Antimicrobial activity against Aspergillus fumigatus MTCC 3008 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1838736,,1,0,,,MIC,,,,CHEMBL363,Aspergillus fumigatus,Aspergillus fumigatus,746128.0,,,MIC,,,,
14959,,,12598227,[],CHEMBL3068917,Antimicrobial activity against Vibrio cholerae MTCC 3906 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14960,,,12598257,[],CHEMBL3068918,Antimicrobial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14961,,,12599183,[],CHEMBL3068919,Antimicrobial activity against Escherichia coli MTCC 443 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14962,,,12599213,[],CHEMBL3068920,Antimicrobial activity against Streptococcus pneumoniae MTCC 1936 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14963,,,12599243,[],CHEMBL3068921,Antimicrobial activity against Clostridium tetani MTCC 449 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14964,,,12599273,[],CHEMBL3068922,Antimicrobial activity against Bacillus subtilis MTCC 441 assessed as growth inhibition after 24-48 hr by NCCLS broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3046940,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1838736,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14965,,,12606007,[],CHEMBL3074021,Antibacterial activity against Escherichia coli MTCC 443 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
14966,,,12606034,[],CHEMBL3074020,Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14967,,,12606061,[],CHEMBL3074022,Antibacterial activity against Salmonella enterica subsp. enterica serovar Typhi MTCC 98 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
14968,,,12606088,[],CHEMBL3074023,Antibacterial activity against Bacillus subtilis MTCC 441 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
14969,,,12606115,[],CHEMBL3074024,Antibacterial activity against Clostridium tetani MTCC 449 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
14970,,,12606142,[],CHEMBL3074025,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 after 24 hr by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045635,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837943,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
14971,,,12607105,[],CHEMBL3072931,Ratio of MBC to MIC for Escherichia coli,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,Ratio,,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,3.0
14972,,,12607132,[],CHEMBL3072932,Ratio of MBC to MIC for Bacillus subtilis,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,Ratio,,,3.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,Ratio,,,,3.0
14973,,,12607159,[],CHEMBL3072933,Ratio of MBC to MIC for Staphylococcus aureus,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,Ratio,,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,3.0
14974,,,12608779,[],CHEMBL3072936,Bactericidal activity against Escherichia coli,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM/ml,,,0.019
14975,,,12608806,[],CHEMBL3072937,Bactericidal activity against Bacillus subtilis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MBC,uM/ml,,,0.019
14976,,,12608833,[],CHEMBL3072938,Bactericidal activity against Staphylococcus aureus,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,MBC,uM/ml,,0.019,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM/ml,,,0.019
14977,,,12608888,[],CHEMBL3072940,Antibacterial activity against Escherichia coli assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,-logMIC,,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,-logMIC,,,,2.61
14978,,,12608915,[],CHEMBL3072942,Antibacterial activity against Bacillus subtilis assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,-logMIC,,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,-logMIC,,,,2.61
14979,,,12608942,[],CHEMBL3072943,Antibacterial activity against Staphylococcus aureus assessed as growth inhibition after 24 hr by tube dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL3045122,Med Chem Res,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,1836335,=,1,0,=,,-logMIC,,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,-logMIC,,,,2.61
14980,,,12629651,[],CHEMBL2319434,Antibacterial activity against Proteus vulgaris by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,8.0
14981,,,12629671,[],CHEMBL2319435,Antibacterial activity against Pseudomonas aeruginosa by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
14982,,,12629691,[],CHEMBL2319436,Antibacterial activity against Shigella dysenteriae by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,4.0
14983,,,12629711,[],CHEMBL2319437,Antibacterial activity against Escherichia coli DH52 by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
14984,,,12629731,[],CHEMBL2319439,Antibacterial activity against Micrococcus luteus ATCC 4698 by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
14985,,,12629751,[],CHEMBL2319438,Antibacterial activity against Bacillus subtilis by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
14986,,,12629771,[],CHEMBL2319440,Antibacterial activity against Staphylococcus aureus ATCC 25923 by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14987,,,12631563,[],CHEMBL2319441,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2311281,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1841890,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14988,,,12658740,[],CHEMBL2328891,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as bacterial growth inhibition measured during 24 hrs incubation at 37 degC by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2321826,Eur J Med Chem,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1851677,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14989,,,12658797,[],CHEMBL2328892,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as bacterial growth inhibition measured during 24 hrs incubation at 37 degC by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2321826,Eur J Med Chem,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1851677,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
14990,,,12658854,[],CHEMBL2328893,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as bacterial growth inhibition measured during 24 hrs incubation at 37 degC by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2321826,Eur J Med Chem,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1851677,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
14991,,,12658911,[],CHEMBL2329203,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as bacterial growth inhibition measured during 24 hrs incubation at 37 degC by two-fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2321826,Eur J Med Chem,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1851677,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14992,,,12680299,[],CHEMBL2340737,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus EMRSA-16 after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
14993,,,12680317,[],CHEMBL2340738,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus EMRSA-15 after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14994,,,12680335,[],CHEMBL2341190,Antibacterial activity against Staphylococcus aureus RN4220 overexpressing MsrA macrolide efflux protein after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14995,,,12682982,[],CHEMBL2341191,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
14996,,,12683000,[],CHEMBL2341192,Antibacterial activity against Staphylococcus aureus XU212 overexpressing TetK tetracycline efflux pump after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
14997,,,12683018,[],CHEMBL2341193,Antibacterial activity against Staphylococcus aureus 1199B overexpressing NorA pump after 18 hrs by MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331436,J Nat Prod,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1869243,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
14998,,,12702328,[],CHEMBL2345782,Antibacterial activity against Vibrio cholerae MTCC 3906 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331438,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1866785,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
14999,,,12702367,[],CHEMBL2345783,Antibacterial activity against Salmonella typhi MTCC 98 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL2331438,Bioorg Med Chem Lett,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1866785,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
